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ABSTRACT
DNA methylation is a repressive epigenetic modifica-
tion that covers vertebrate genomes. Regions known
as CpG islands (CGIs), which are refractory to DNA
methylation, are often associated with gene promot-
ers and play central roles in gene regulation. Yet
how CGIs in their normal genomic context evade
the DNA methylation machinery and whether these
mechanisms are evolutionarily conserved remains
enigmatic. To address these fundamental questions
we exploited a transchromosomic animal model and
genomic approaches to understand how the hy-
pomethylated state is formed in vivo and to dis-
cover whether mechanisms governing CGI forma-
tion are evolutionarily conserved. Strikingly, inser-
tion of a human chromosome into mouse revealed
that promoter-associated CGIs are refractory to DNA
methylation regardless of host species, demonstrat-
ing that DNA sequence plays a central role in specify-
ing the hypomethylated state through evolutionarily
conserved mechanisms. In contrast, elements distal
to gene promoters exhibited more variable methyla-
tion between host species, uncovering a widespread
dependence on nucleotide frequency and occupancy
of DNA-binding transcription factors in shaping the
DNA methylation landscape away from gene promot-
ers. This was exemplified by young CpG rich lineage-
restricted repeat sequences that evaded DNA methy-
lation in the absence of co-evolved mechanisms tar-
geting methylation to these sequences, and species
specific DNA binding events that protected against
DNA methylation in CpG poor regions. Finally, trans-
plantation of mouse chromosomal fragments into
the evolutionarily distant zebrafish uncovered the
existence of a mechanistically conserved and DNA-
encoded logic which shapes CGI formation across
vertebrate species.
INTRODUCTION
DNA methylation on CpG dinucleotides in vertebrate
genomes is associated with transcriptional repression (1,2)
and is epigenetically inherited during cell division to prop-
agate repressive chromatin states (3–5). Conversely, short
contiguous roughly 1–2 kb regions of CpG-rich DNA,
known as CpG islands (CGIs), are interspersed through-
out the genome and are resistant to DNA methylation
(6,7). CGIs are found associated with 60–70% vertebrate
gene promoters and are a central and evolutionarily con-
served feature at these sites (8,9). CGIs function to recruit a
family of ZF-CxxC DNA binding domain-containing pro-
teins that associate with chromatin-modifying activities to
remodel chromatin structure at gene promoters and con-
tribute to gene regulation (10–12). Importantly, promoter-
associated CGIs are usually free of DNA methylation re-
gardless of the transcriptional state of the associated gene
and are hypomethylated in most tissues (13–16), with only
a subset of weak promoter-associated CGIs undergoing
changes in DNA methylation during development (14,17–
19). In addition to promoter-associated CGIs, an addi-
tional class of hypomethylated elements has been identified
away from gene promoters that appear to function as dis-
tal gene regulatory elements, often encompassing enhancers
(8,13,15,16,20). These regions tend to be hypomethylated in
a subset of tissues, suggesting that the mechanisms under-
pinning their methylation state may differ from that of clas-
sical promoter-associated CGIs.
Despite our ever-increasing knowledge of DNA methy-
lation landscapes in diverse vertebrate genomes, the princi-
ples andmechanisms that specify these patterns and protect
CGIs and distal regulatory elements from DNA methyla-
tion is underexplored, particularly with respect to how these
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mechanisms function in their normal genomic context on
chromosomes and during animal development. This is due
to the fact that most of our information about these pro-
cesses has relied on interrogating CGIs and their methy-
lation states by inserting short DNA sequences (natural
or synthetic) into engineered acceptor sites in cell culture
systems (12,21–24). These studies have suggested that nu-
cleotide features may function as amolecular signal to spec-
ify regions that should be refractory to the placement of
DNA methylation (12,21–24). Alternatively, in some in-
stances sequence-specific transcription factor binding has
been linked to protection of the underlying DNA sequence
from DNA methylation (22,23,25–27). Given that genomic
context and tissue specific features play central roles in the
way DNA elements function, it still remains poorly under-
stood how significant these, or other mechanisms, are in
specifying how hypomethylated regions of DNA (HMRs)
form at a chromosome scale in animals.
To explore the mechanisms that shape CGI methylation
state in a genomic context and to directly test whether these
properties are evolutionarily conserved in vertebrates we
have exploited a transchromosomic mouse animal model
(Tc1) (28) in which most of human chromosome 21 has
been stably transplanted into the mouse nuclear environ-
ment. Using genomic approaches we examined howHMRs
are specified within 42 Mb of this human chromosome
in developmentally distinct tissues. This revealed that ir-
respective of host species, CpG-rich promoter-associated
CGIs are almost invariantly hypomethylated. In contrast,
we discovered that distal elements are prone to alterna-
tive DNA methylation states depending on the host species
and that this relies on both DNA sequence and transcrip-
tion factor binding. Strikingly, these observations hold true
when mouse chromosomal fragments are transposed into
zebrafish, demonstrating for the first time that these gen-
eral mechanisms are functionally conserved across diver-
gent vertebrate species. Together this reveals that a DNA
sequence-encoded logic and evolutionarily conservedmech-
anisms relying on the interplay between DNA features and
transcription factor binding shape the DNA methylation
based epigenome in vertebrate chromosomes.
MATERIALS AND METHODS
Tc1 mouse sample preparation
The Tc1 mouse line was maintained as previously described
(28). Tc1 mice were bred by crossing female Tc1 mice to
male (129S8 × C57BL/6J) F1 mice and were housed in the
Biological ResourcesUnit underHomeOffice Licence (PPL
80/2197). Genomic DNA was extracted from fresh frozen
Tc1 mouse liver and testis tissue using Genomic-tip 100/G
kit (QIAGEN).
Transposition of BAC DNA sequences into the zebrafish
genome
Four mouse BACs were engineered to contain a GFP re-
porter driven by the eF1alpha promoter, and an inverted
Tol2 transposition cassette (iTol2) flanking an ampicillin re-
sistance gene (29) by BAC recombineering (Gene Bridges).
BAC DNA was prepared using the Nucleobond BAC
preparation kit and transposase RNA was generated us-
ing the SP6 RNA polymerase mMessage Machine kit (Am-
bion). BAC DNA and transposase RNA were introduced
into zebrafish embryos by microinjection soon after fer-
tilisation. GFP positive embryos were collected at 28–30
hpf and genomic DNA was extracted using the QIAGEN
DNeasy Blood and Tissue Kit.
BioCAP
BioCAP-sequencing was performed as described previ-
ously (30) in Tc1 mouse and Tc0 (wildtype) mouse testis
and liver tissue in biological duplicate, and for zebrafish
embryos containing integrated mouse BAC DNA. Hu-
man and mouse BioCAP datasets were detailed previously
(GSE43512).
HMR peak-calling and differential methylation analysis
Tc1 BioCAP-sequencing reads were aligned to a composite
genome containing mouse chromosomes and human chro-
mosome 21 using bowtie (31). HMRs were identified in
Tc1 mouse tissues from BioCAP-sequencing traces using
MACS1.4 (32) with settings –tsize = 50 –bw = 300 –mfold
= 10,30 –pvalue = 1e-5 –verbose = 10 -g 4.8e+8 and in-
cluding the use of an input control. Only HMRs that were
identified in both biological replicates were retained. Hu-
man HMRs are detailed in (8). The human chromosome
21 in the Tc1 mouse has some rearrangements and duplica-
tions (33). To account for this, HMRs overlapping break-
points or deleted regions were removed from the analysis
and read values were scaled appropriately in duplicated re-
gions. Differential methylation between species was identi-
fied if an HMR exhibited a greater than 2-fold change in
BioCAP reads between the human and Tc1 mouse experi-
ments using BAM files normalised to the same read count
across chromosome 21. To compare HMRs onmouse chro-
mosomes, HMR sites were identified in the Tc1 and Tc0
(wildtype) mouse usingMACS1.4 (32) and compared as in-
dicated above. Zebrafish Bio-CAP reads were aligned to a
composite genome containing zebrafish chromosomes and
each individual BAC sequence using bowtie-2 (34).
Determining CpG density and GC content
CpG density and GC content of individual HMR regions
was calculated based on the underlying DNA sequence for
HMRs that were shared between human and Tc1 mouse or
were species-specific. A matched background control was
generated by randomly shifting HMR coordinates to an-
other position on chromosome 21. CpG density and GC
content was plotted as frequency distribution plots for liver
and testis tissue.
Genomic repeat age analysis
Repeat elements that overlapped the summit of HMR el-
ements were analysed for repeat age. Repeat age was es-
timated by determining the number of substitutions from
the repeat consensus sequence (Repeat-Masker track from
UCSC, milliDiv column) and dividing this number by the
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estimated mutation rate for mammalian species, which is
2.2 × 10−9 per year (35,36). The distribution of repeat age
was displayed as box plots for shared and species-specific
HMRs.
Transcription factor binding
Transcription factor binding sites were identified using the
MACS1.4 peak caller with the same settings as were used to
identify HMRs above (32). Shared or species-specific tran-
scription factor binding events were determined by intersec-
tion of transcription factor binding sites identified in human
and Tc1 mouse.
Gene expression analysis
Gene expression data (reads per kilobase per million
mapped reads, RPKM) was used to compare the expression
of genes with an HMR overlapping their promoter (TSS ±
500bp) (36). Genes with a promoter-associated HMR were
segregated depending on whether the HMR was shared be-
tween human and Tc1 mouse, or was species-specific.
Graphical representation
Heatmaps and metaplots were generated using Homer an-
notatePeaks and plotted in R. Venn diagrams were plotted
in R using the package VennDiagram. Boxplots were plot-
ted in R using the package boxplot. Scatterplots were gen-
erated in R.
Multiplex bisulfite sequencing
Bisulfite conversion of 250 ng human and two replicates
of Tc1 mouse liver genomic DNA was performed using
the EZ DNA Methylation-Gold Kit (Zymo Research).
10 picogram (pg) unmethylated and 10 pg methylated
Arabidopsis thaliana BAC DNA (F24B22 and F19K16
respectively) was spiked into the three conversion re-
actions to control for bisulfite conversion (Diagenode
DNA Methylation control package, EF-100-0040). PCR-
amplified DNA was pooled for each replicate sample
and Illumina sequencing libraries were prepared using the
NEBNext DNA Library Prep Master Mix Set for Illu-
mina (NEB). Indexed libraries were combined and se-
quenced on a MiSeq machine (Illumina). Sequencing data
was analysed using the BisMark software from Babra-
ham Bioinformatics (http://www.bioinformatics.babraham.
ac.uk/projects/bismark/) (37). The two Tc1 biological repli-
cates were highly similar, and were averaged for visualisa-
tion. Primer sets used for bisulfite sequencing are available
on request.
RESULTS
Hypomethylated regions (HMRs) on human chromosome
21 are largely recapitulated in the transchromosomic mouse
model
We recently demonstrated that many features of the CGI
system are shared across vertebrate species (8).This led us to
hypothesize that the mechanisms that specify DNA methy-
lation state at CGIs may be evolutionarily conserved and
rely on the underlying DNA sequence. To directly test this
hypothesis, we exploited a transchromosomic mouse model
(known as Tc1) that has been engineered to contain approx-
imately 42 Mb of human chromosome 21 on a single in-
dependently segregating chromosome (28). This interesting
trans-species model system provides a unique opportunity
to ask how hypomethylated regions of DNA (HMRs) are
formed and maintained in their natural genomic context in
a developing animal following chromosome-scale introduc-
tion of DNA from one vertebrate, human, into the nuclear
environment of second vertebrate, mouse. Importantly, it
also allowed us to ask whether human chromosomal DNA-
encoded information is sufficient to recapitulate the human
host DNAmethylation patterns in the nuclear environment
of mouse, and in doing so test whether these mechanisms
are evolutionarily conserved during development.
To answer these fundamental questions we isolated DNA
from Tc1 mouse liver and testis and used biotinylated CxxC
affinity purification (BioCAP) coupled to massively paral-
lel sequencing to isolate regions of the genome contain-
ing hypomethylated DNA, and mapped these regions onto
the mouse genome plus human chromosome 21 (30,38).
We chose liver and testis to use as experimental tissues be-
cause their structure is highly similar in mammals in terms
of cellular composition (39–41) and gene expression pro-
files (42–44), enabling a meaningful and direct comparison
of BioCAP-seq signal on human chromosome 21. BioCAP
experiments were carried out in duplicate with individual
experiments correlating extremely well (R2 > 0.95, Supple-
mentary Figure S1), further supporting the robustness of
our approach (8,30). To ensure that the presence of the hu-
man chromosome did not affect the function of the DNA
methylation system in the Tc1 mouse, we compared HMRs
on the mouse chromosomes in the Tc1 mouse to HMRs
formed in the same tissues in wild-type mice of the same ge-
netic background. Importantly, HMRs on the Tc1 mouse
chromosomes were indistinguishable from those of wild-
type mice (Supplementary Figure S2A-F). Therefore, the
presence of human chromosome 21 in the Tc1 mouse does
not affect the function of the host DNA methylation ma-
chinery, indicating that the Tc1 mouse is a suitable model
to study HMR formation on the newly introduced human
chromosome 21.
To investigate how HMRs form on human chromosome
21 in the mouse nuclear environment, we identified HMRs
in developmentally distinct testis and liver tissue from the
Tc1 mouse and directly compared these to HMRs formed
on chromosome 21 in the corresponding human tissues (8).
This revealed that the majority of human HMRs (85% in
testis and 82% in liver) were recapitulated in the Tc1 mouse
(Figure 1A and B). This was evident when BioCAP signal
was plotted at all human chromosome 21 HMRs in the hu-
man and corresponding Tc1 mouse tissues (Figure 1C and
D, left, and Figure 1E). To ensure that the HMRs formed
on human chromosome 21 in the Tc1 mouse were func-
tioning as they normally do in human tissues, we exam-
ined whether they were also modified by H3K4me3, a hi-
stone modification placed at HMRs by ZF-CxxC domain
containing histone methyltransferase complexes (12,45). In
6696 Nucleic Acids Research, 2016, Vol. 44, No. 14
H
um
an
 li
ve
r H
M
R
s
H
um
an
 te
st
is
 H
M
R
s
A
B D
C
0 +5-5 0 +5-5
BioCAP H3K4me3
Tc1 Tc1
0 +5-5
Distance from
centre of HMR
0 +5-5
Distance from
centre of HMR
BioCAP H3K4me3
Tc1 Tc1
5 kb
BRWD1
80
80
0
0
80
0
80
0
Tc1
H
s 
ch
r2
1
Tc1
H
s 
ch
r2
1
HLCS PSMG1
10 kb10 kb
GRIK1
E
Tc1 liver BioCAP (reads)
H
um
an
 li
ve
r B
io
C
A
P
 (r
ea
ds
)
2 8 32 128 512 2048
2
8
32
128
512
2048
Tc1 testis BioCAP (reads)
2 8 32 128 512 2048
2
8
32
128
512
2048
Tc1 Tc1
H
um
an
 te
st
is
 B
io
C
A
P
 (r
ea
ds
)
Figure 1. Hypomethylated regions (HMRs) on human chromosome 21 are largely recapitulated in the transchromosomic mouse model. (A and B) Profiles
of non-methylated DNA (BioCAP-seq) at three regions on human chromosome 21 in human (upper) and in Tc1 mouse (lower, inverted) liver (A) and
testis (B) tissues. Genes are depicted above the BioCAP traces. (C and D) Heatmaps depicting BioCAP (left) and H3K4me3 ChIP-seq (right) signal across
human chromosome 21 HMRs in the human and Tc1 mouse liver (C) and testis (D) tissues. Signal is ranked according to HMR length and aligned to the
centre of the HMR. Scalebar in kb. (E) Scatterplots of BioCAP-seq reads for human and Tc1 mouse at all human HMRs from liver (left) and testis tissue
(right).
agreement with the observation that the majority of HMRs
form normally on human chromosome 21 in the Tc1 mouse
tissues, we also observed robust H3K4me3 ChIP-seq sig-
nal at these sites in liver and testis tissue (Figure 1C and
D, right). Overall, the majority of HMRs on human chro-
mosome 21 and their stereotypical chromatin modifica-
tions are faithfully recapitulated when the chromosome is
transplanted into mouse. This indicates that, for the most
part,DNA sequence is sufficient to shapeDNAmethylation
state at HMRs during vertebrate development, and further-
more that the systems required to achieve HMR formation
at these sites are highly conserved between two vertebrate
species, human and mouse.
Identification of species-specific HMRs
AlthoughHMRs on chromosome 21 were for the most part
appropriately specified in the Tc1 mouse, we observed a
number of locations where DNAmethylation was gained or
lost in the Tc1 mouse when compared to the same locus in
human (Figures 1E and 2A andB, upper panels). This inter-
esting observation suggests that some species-specific fea-
turesmust also contribute toHMRspecification. To explore
these changes in more detail, we used targeted deep bisul-
fite sequencing to examine at single base pair resolution the
DNA methylation state at a number of these loci. In all
cases, this revealed quantitative differences in DNA methy-
lation across a range of CpG densities in agreement with
the altered magnitude of BioCAP-seq signal. This is evi-
dent when individual loci were visualized (Figure 2A and B,
lower panels) and more broadly at a set of 37 differentially
methylatedHMRsbut not control loci (Supplementary Fig-
ure S3). We refer to these differentially methylated loci as
species-specific HMRs (ssHMRs) to distinguish them from
the majority of HMRs that display invariant methylation
patterns when chromosome 21 resides in either Tc1 mouse
or human tissues.
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Figure 2. Identification of species-specific HMRs. (A and B) BioCAP-seq traces across two human-specific (A) and two Tc1-specific (B) HMRs on human
chromosome 21. Species-specific HMRs (ssHMRs) are indicated by a horizontal bar below the BioCAP-seq traces (upper). Bisulfite sequencing at species-
specific HMRs confirms alterations in methylation at these sites (lower). Bisulfite amplicons (BA) are depicted by a horizontal black bar, CpG dinucleotides
by a vertical line and themethylation status of each CpG in human or Tc1 liver is depicted as a vertical line between 0 and 100%. (C) Scatter plot of BioCAP-
seq reads for human and Tc1 mouse at all HMRs to illustrate human and Tc1-specific HMRs in liver (upper) and testis (lower). (D and E) Heatmaps of
BioCAP-seq signal in human and Tc1 mouse liver (D) and testis (E) tissues illustrate that a subset of HMRs are differentially methylated. Heatmaps
are ranked according to HMR length and aligned to the centre of the HMR with shared (upper), human-specific (middle), and Tc1-specific (lower) sites
clustered together. Scalebar in kb. (F) Venn diagrams depicting the overlap between human-specific HMRs (upper) or Tc1-specific HMRs (lower) from
different tissues.
Differential analysis of BioCAP-seq signal over the com-
bined set of Tc1 and human HMRs revealed a surprisingly
large number of ssHMRs (244 in liver and 209 in testis)
(Figure 2C–E). At these sites there was a tendency for the
hypomethylated state to predominate in the Tc1 tissue, ac-
counting for 68–69% of ssHMRs (Figure 2C-E). Interest-
ingly, human-specific HMRswere usually unique to one tis-
sue (96%) (Figure 2F, upper), suggesting that HMR forma-
tion at these sites may rely on tissue-specific events. In con-
trast, fewer Tc1-specific HMRs were unique to one tissue
(66%) (Figure 2F, lower) suggesting that species-specific,
but tissue-invariant, activities contribute to HMR forma-
tion at the remaining (33%) Tc1-specific HMRs.
The majority of species-specific HMRs are not directly re-
lated to changes in gene expression and are distal to gene pro-
moter regions
The identification of ssHMRs on human chromosome 21
in the human and mouse nuclear environments provided a
unique opportunity to examine these differences in detail
and discover the mechanisms that specify these methylation
patterns. Given the historical relationship between CGIs
and gene promoters, we first examined whether ssHMRs
were associated with gene transcriptional start sites (TSSs).
This revealed that ssHMRs are infrequently associated with
TSSs (38/244 for liver and 30/209 for testis), and that
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the majority of these sites are located away from gene
promoters (Figure 3A). Furthermore, when we examined
the magnitude of change in BioCAP signal at ssHMRs,
those found away from gene promoters showed larger alter-
ations suggesting that these sites are more prone to nuclear
environment-dependent changes in DNAmethylation (Fig-
ure 3B). In the small number of instances where ssHMRs
overlapped a gene promoter, there was no obvious relation-
ship between the observed differences in DNA methylation
and host gene expression patterns, suggesting that these al-
terations are not related to transcriptional changes (Supple-
mentary Figure S4).
Species-specific HMRs in the Tc1 mouse are CpG-rich and
often associated with young repetitive DNA elements
Given the overrepresentation of ssHMRs in regions of
the genome distal to TSSs, we examined in more detail
the DNA sequence features at these sites to understand
if this could explain their species-specific methylation pat-
terns and provide insight into the mechanisms shaping their
methylation state. We initially focused on CpG dinucleotide
frequency and GC content, based on our previous observa-
tions that these nucleotide features are almost universally
elevated amongst regions in vertebrate genomes that lack
CpG methylation (8). Initially we examined Tc1-specific
HMRs as they were the most abundant group of ssHMRs
and directly compared their nucleotide features to shared
HMRs. In general, shared HMRs on human chromosome
21 in both the human and Tc1 mouse were characterized
by classical CpG island nucleotide features, with CpG den-
sity and GC content above the genome average, consistent
with their invariantly hypomethylated state (Figure 4A and
B). Somewhat surprisingly, Tc1-specific HMRs had highly
elevated CpG density and GC content, even eclipsing the
nucleotide frequencies characteristic of the non-methylated
state at most shared HMRs (Figure 4A and B). This indi-
cates that despite their CGI-like nucleotide composition, a
subset of CpG andGC-rich regions on human chromosome
21 are actively targeted by the DNAmethylation machinery
in human tissues, and yet these same sequences evade DNA
methylation in the Tc1 mouse.
CpG and GC-rich sequences that are methylated in hu-
man tissues are often associated with repetitive or parasitic
DNA elements (46). Targeted methylation of these DNA el-
ements is a common evolutionary strategy to suppress the
potentially deleterious effects on the host genome (1,47).
In the human genome, primate-specific repetitive elements
have emerged recently enough that their CpG frequency
remains high in the face of evolutionary mechanisms that
drive down the overall frequency of CpG dinucleotides in
vertebrate genomes (48–52). Therefore some of these ele-
ments display an elevated CpG density compared to the
surrounding genome, much like CGI elements (51,53). We
previously showed that in some cases, primate-specific re-
peats can possess latent gene regulatory potential and be-
come activated in the mouse (36). When the average age
of repeats associated with either shared HMRs, human-
specific HMRs, and Tc1 mouse-specific HMRs were com-
pared it was evident that young, newly acquired repeti-
tive elements were overrepresented in Tc1 mouse-specific
HMRs (Figure 4C and Supplementary Figure S5). Interest-
ingly, however, loss of methylation at most of these sites was
unrelated to gene transcription, as examination of ChIP-
seq for RNA polymerase II (Pol II) in liver tissue at Tc1-
specific HMRs revealed that only a subset (20%) of these
sites acquired RNA Pol II occupancy. This is evident at in-
dividual loci (compare Figure 4D and E to F) and through
analysis of RNAPII occupancy at Tc1-specific HMRs com-
pared to transcribed shared HMRs (Figure 4G). Together,
this indicates that Tc1-specific HMRs do not simply re-
sult from unmasking of dormant or cryptic gene promot-
ers with latent regulatory potential (36) and supports the
idea that species-specific trans-acting factors actively tar-
get DNA methylation to these sites. Therefore, our obser-
vations reveal that in the absence of co-evolved mechanisms
that specificallymethylate young human repeat elements, el-
evated CpG andGC content is sufficient to protect these se-
quences from DNA methylation during development. To-
gether these interesting interspecies observations provide
new and widespread evidence that mechanisms that sense
CpG dinucleotide frequency contribute centrally to evasion
of the DNA methylation machinery.
Species-specific transcription factor binding is widely associ-
ated with species-specific HMR formation
Elevated nucleotide features at young human repetitive se-
quences appear to contribute to their hypomethylated state
in the Tc1 mouse, however this cannot explain how a subset
of human HMRs on human chromosome 21 acquire DNA
methylation in the mouse nuclear environment. To under-
stand the features that drive formation of these human-
specific HMRs we again examined their underlying nu-
cleotide features. In contrast to Tc1 mouse-specific HMRs,
human-specific HMRs were characterized by CpG density
andGC content above the genome average, but significantly
below those found at classical CGI elements (Figure 5A-B).
This suggests that mechanisms protecting these sites from
methylation in human tissues do not rely on classical CGI-
like nucleotide frequencies.
We and others have recently identified a subset of HMRs
that are differentially methylated depending on tissue type
(8,14–17,54). These tissue-specific HMRs often correspond
to distal regulatory elements, including enhancers. Much
like the human-specific chromosome 21 HMRs, these sites
have low CpG dinucleotide frequency and GC content.
Distal regulatory elements usually correspond to sites of
transcription factor occupancy, which has been proposed
to protect the underlying binding site and surrounding
DNA from methylation (20,22,23,26,27,55). Therefore, an
interesting possibility is that human-specific HMRs at re-
gions exhibiting an intermediate-to-low CpG frequency
and GC content may result from species-specific DNA
binding events. To investigate this possibility, we exam-
ined the ChIP-seq profiles of three DNA binding factors
CEBPA, HNF4A and CTCF in the human and Tc1 mouse
liver (36). Despite the conserved nature of these DNA bind-
ing factors between human and mouse, we identified a large
number of species-specific DNAbinding events on chromo-
some 21, likely due to subtle changes in binding site pref-
erence (Supplementary Figure S6A). An examination of
Nucleic Acids Research, 2016, Vol. 44, No. 14 6699
A B
TS
S
N
on
-T
S
S
326 121
13769 223
Tc1
Tc1
255 110
11861 267
Tc1
Tc1
1
2
3
4
5
Lo
g2
(F
ol
d 
ch
an
ge
 H
M
R
 re
ad
co
un
t)
Tc1
TS
S
N
on
-T
S
S
*
TS
S
N
on
-T
S
S
n.s.
Tc1-specific HMR
Human-specific HMR
Shared HMR
Figure 3. The majority of species-specific HMRs are distal to gene promoter regions. (A) Venn diagrams depicting the overlap between HMRs in the
human and Tc1 mouse tissue. HMRs are segregated into those located at transcription start site (TSS ± 500bp) (upper) and those found away from TSSs
(lower). Human-specific HMRs are coloured in dark grey, shared HMRs in grey and Tc1-specific HMRs in light grey. (B) Boxplots depicting fold-change
in BioCAP signal between Tc1 mouse and human at Tc1-specific HMRs located at a gene TSS or elsewhere in the chromosome. Tc1-specific HMRs away
from gene TSSs exhibit a greater fold-change in BioCAP signal compared to those at gene TSSs. Significance values calculated using Welch’s T-test (*P <
0.05).
these species-specific transcription factor binding events re-
vealed that human-specific HMRs frequently overlap tran-
scription factor binding events that are unique to the hu-
man liver. For example, the 3′ end of the WDR4 gene is
characterized by HNF4A and CEBPA binding events that
only occur in the human liver, and this corresponds to a
human-specific HMR (Figure 5C). Strikingly, 31% (23/75)
of human-specific HMRs intersected at least one transcrip-
tion factor binding event that was unique to the human
liver tissue (Figure 5D and Supplementary Figure S6B).
Therefore, differential transcription factor binding appears
to be a central feature of species-specific methylation states
at sites with intermediate CpG and GC content on human
chromosome 21.
Given the clear overlap between transcription factor
binding and ssHMRs in human tissue, we wondered
whether Tc1 mouse-specific transcription factor binding
events may also be implicated in the methylation state of
some ssHMRs in mouse. When we examined Tc1-specific
HMRs we again observed that nearly a third (47/169) of
these sites overlapped with a Tc1-unique transcription fac-
tor binding event (Figure 5F). For example, downstream
of the human TRPM2 gene an HMR is hypomethylated
in the Tc1 mouse and bound by both HNF4A and CTCF.
In human these binding events are absent and the region
is methylated (Figure 5E and Supplementary Figure S6C).
Strikingly, the methylation state of approximately one-third
of all species-specific chromosome 21 HMRs appear to be
related to the binding profiles of just three transcription fac-
tors (Figure 5D and F). This suggests that if more tran-
scription factors were examined, the methylation state of a
large proportion of species-specific chromosome 21 HMRs
might correspond to these events. Therefore together, our
in vivo interspecies experiments demonstrate the breadth
with which DNA binding transcription factor occupancy
can shape DNA methylation profiles at sites in the genome
that have low CpG density and GC content, an observation
that is further supported by recent in vitro experiments that
also suggest DNAbinding events contribute to local methy-
lation profiles (20,22,23).
The principles shaping HMR formation are DNA encoded
and conserved across vast expanses of divergent vertebrate
evolution
Although it is clear in the Tc1 mouse that a subset of sites
on human chromosome 21 can exist in alternative methy-
lation states depending on the host species, the majority
of HMRs throughout the human chromosome form com-
pletely normally (Figure 2C–E). This suggests that the gen-
eral mechanisms specifying DNAmethylation patterns and
protecting CGIs from methylation are for the most part in-
tact and conserved across 75 million years of evolutionary
divergence between human and mouse. We recently demon-
strated that features of a CGI-like system exist in most,
if not all, branches of vertebrate evolution (8). If DNA
sequence is indeed the central driver in HMR formation
and the mechanisms driving these methylation states are
functionally conserved in divergent vertebrate species then
one would predict that the transplantation of mammalian
DNA sequences into evenmore distantly related vertebrates
would also result in the accurate specification ofHMRsdur-
ing animal development.
To test this hypothesis, we introduced large chromoso-
mal fragments of mouse DNA into the zebrafish genome
and used BioCAP-seq to examine how the resulting methy-
lation profiles compared to the profiles observed in mouse
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line). A background control is indicated (grey). (C) Boxplots depicting age of repeats (in million years) associated with HMRs in liver (left) and testis tissue
(right). HMRs are segregated into those that are shared in human and Tc1 mouse (purple) and are Tc1-specific (pink). The difference in repeat age between
shared and Tc1-specific HMRs is significantly different as calculated by aMann–Whitney U test (*P< 5 × 10−4). (D and E) Snapshots of two Tc1-specific
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tissues. To achieve this, four mouse bacterial artificial chro-
mosomes (mBACs) each containing approximately 200 kb
of genomic sequence were introduced into the genome of
the fertilized zebrafish zygote by Tol2-mediated transposi-
tion (29). When we examined the resulting methylation pro-
files of themouseDNAsequences in 28–30 hours post fertil-
isation (hpf) zebrafish embryos, we observed that promoter-
associated mouse HMRs were appropriately specified, in-
cluding both typical 1–2 kb HMRs (Figure 6A and B) and
broad HMRs, which tend to be associated with genes im-
portant for development (Figure 6C) and that the BioCAP-
seq signal at HMRs on the mouse DNA in zebrafish corre-
lated linearly with the BioCAP-seq signal in mouse tissues
(Figure 6F–H). Together this indicates that the principles
driving protection of these elements fromDNAmethylation
are DNA encoded and conserved across vertebrate evolu-
tion.
Interestingly, a small number of new HMRs were formed
on the mouse BACs integrated into zebrafish, much like
the species-specific HMRs that were observed in the Tc1
mouse. When we examined these sites in more detail they
again corresponded to CpG and GC rich regions within
the mBAC including an exonic region of the Zfp623 gene
(Figure 6D). Importantly, several sites where zebrafish spe-
cific HMRs formed in the mBACs corresponded to small
clusters of CpG rich LTR repeats, including intracisternal A
particles (IAPs) and the ERV1 element MMVL30-int, that
are restricted to the mouse lineage, and are absent from the
zebrafish genome (Figure 6A and E, Supplementary Fig-
ure S7A). Many of the LTR retrotransposons present on
themBACs exhibit CpGdensity comparable to endogenous
CpG islands (Supplementary Figure S7B) and, therefore, in
amanner similar to young primate specific repeat sequences
in the Tc1 mouse, zebrafish presumably lacks co-evolved
mechanisms to drive DNA methylation to these mouse re-
peat regions. Consequently, the elevated CpG and GC con-
tent of these repeat sequences appears to render them re-
fractory to methylation further supporting the argument
that nucleotide content is a central and evolutionarily con-
served DNA encoded feature shaping HMR formation.
Therefore, by examining the principles that shape HMR
formation in vivo across distinct vertebrate organisms that
have undergone extensive divergent evolution, we find that
nucleotide content, in particular CpG and GC richness, is a
central feature shaping HMR formation. Furthermore, the
fact that most mouse HMRs, when situated in their nor-
mal genomic context, formed accurately in zebrafish (Fig-
ure 6F–H) reveals quite remarkably that the mechanisms
driving stereotypical HMR formation, particularly at gene
promoters, are highly conserved, despite 450 million years
divergent evolution.
DISCUSSION
Themechanisms that form andmaintain epigenomes in vivo
are very poorly understood. Recently, cell culture-based ap-
proaches inserting small DNA fragments into the genome
have suggested some principles that may contribute to for-
mation of DNAmethylation states (22–24). However, these
approaches do not examine how DNAs behave in their nat-
ural genomic context, are limited in the total amount of
DNA sequence they interrogate, and do not capture the
divergent developmental trajectories that ultimately shape
chromosomal DNA methylation patterns in tissues. There-
fore, to overcome these limitations we have exploited a tran-
schromosomic mouse model and examined developmen-
tally distinct tissues to discover that the majority of HMRs
on human chromosome 21 are appropriately recapitulated
when transplanted into the mouse nuclear environment, in-
dicating that the underlying DNA sequence and genomic
context is largely sufficient to drive the observed methyla-
tion patterns in vertebrate organisms.
A subset of regions distal to classical promoter-
associated CGIs showed species-specific methylation pat-
terns. Interestingly, CpG and GC-rich regions associated
with young repeat sequences became hypomethylated in
the mouse nuclear environment, and also in experiments
where mouse BACs were integrated into zebrafish, appar-
ently in the absence of mechanisms that would normally
drive methylation to these sites. This feature is uniquely re-
vealed through our interspecies experiments and demon-
strates that the mechanisms which evolved to recognize re-
peat elements and methylate them can override the inher-
ent capacity of CpG and GC-rich sequences to evade DNA
methylation, presumably as a requirement to protect the
genome against the activity of these potentially deleteri-
ous elements. These protection mechanisms may rely on
the activity of piwi RNA (piRNA) clusters that encode a
historical memory of transposition events from invading
retroviruses and recruit PIWI proteins to endogenous trans-
posons resulting in their methylation (56,57). Alternatively,
a class of KRAB zinc finger DNA binding proteins ap-
pears to rapidly evolve the capacity to recognize emerg-
ing classes of repetitive DNA sequence and similarly tar-
gets them for DNA methylation (58,59). Importantly, in
the absence of co-evolved mechanisms that target DNA
methylation to these repetitive sequences, it appears that
CpG and GC-richness renders these DNA sequences re-
fractory to DNA methylation, much like classical HMRs,
supporting the idea that the cell uses CpG and GC rich-
ness as a cue to protect against DNA methylation. In con-
trast to CpG and GC-rich regions, the methylation state
of DNA sequences with intermediate CpG and GC con-
tent are frequently defined by species-specific DNA binding
events, providing new widespread experimental evidence
that site-specific DNA binding factor occupancy, in addi-
tion to DNA sequence features, can play a central role in
shaping DNA methylation patterns at these sites. Together
these observations reveal that CpG and GC nucleotide fea-
tures and protein-based DNA binding events defined by
DNA sequence are central determinants in shaping methy-
lation patterns on chromosomal DNA sequences in vivo
during development. Furthermore, by transplantation of
mouse chromosome fragments into zebrafish we discovered
that these general principles are conserved across vast ex-
panses of divergent vertebrate evolution, uncovering the ex-
istence of a highly conserved and DNA encoded logic that
shapes methylation patterns in the vertebrate epigenome.
Our observation that CpG and GC nucleotide content
is a central determinant in protecting chromosomal DNA
from DNA methylation is in agreement with observations
that short synthetic or bacterial CpG and GC-rich DNA
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Figure 6. The DNA encoded principles that underpin HMR formation are conserved across vast expanses of divergent evolution. (A) BioCAP-seq profile
of a mouse chromosomal DNA fragment introduced into the zebrafish genome and analysed at 28–30 h post-fertilisation (hpf). The BioCAP signal from
three representative mouse cell-types ES cells, liver and testis (green, red and blue traces) and the BioCAP trace observed for this locus in the developing
zebrafish (grey) is indicated. CpG density and GC content are depicted in black. All four mouse HMRs form on the mouse BAC DNA in the zebrafish
embryo and a cluster of repetitive LTR elements in the centre of the mouse BAC form zebrafish-specific HMRs. (B) A snapshot of a promoter-associated
mouse HMR. (C) A snapshot of a broadly hypomethylated region. (D) A snapshot of a zebrafish-specific HMR region that forms at a CpG and GC-rich
mouse exonic region that is normally methylated in mouse tissues. (E) A snapshot illustrating a cluster of mouse LTR elements which are CpG dense and
become hypomethylated in zebrafish. (F–H) Scatterplots comparing BioCAP-seq read counts at mouse HMRs in zebrafish with mouse liver (F), testis (G)
and embryonic stem cells (H).
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sequences can often evade the DNA methylation machin-
ery when inserted into vertebrate genomes (12,21,22). This
can in many instances be achieved even if sequences ap-
parently lack motifs necessary for site-specific occupancy
of DNA binding transcription factors, suggesting that al-
ternative mechanisms must exist to sense and protect these
CpG and GC-rich regions from DNA methylation. This
could be achieved by evolutionarily conserved ZF-CxxC
domain containing proteins that bind specifically to non-
methylated CpG dinucleotides (10,60) and associate with
chromatin modifying activities that create chromatin envi-
ronments that are refractory to DNA methylation. For ex-
ample, H3K4me3 is targeted to CGIs by several ZF-CxxC
proteins (10,12) and can inhibit DNA methyltransferase
function on chromatin in vivo (61–63). Furthermore, the
KDM2BZF-CxxC domain-containing protein functions as
an H3K36me1/me2 demethylase and is part of the poly-
comb repressive complex 1 that appears to protect a sub-
set of CGIs from DNA methylation (11,64–68). This oc-
clusion of the DNA methylation machinery is likely re-
inforced by mechanisms that can actively remove DNA
methylation, such as the TET oxygenases that are putative
DNA demethylase enzymes and occupy CGIs via their ZF-
CxxC domains (69–72). Together these observations sug-
gest that chromatin-modifying activities targeted to CGIs
by ZF-CxxC domain containing proteinsmay play a central
and evolutionarily conserved role in protecting CGIs from
DNA methylation and shaping DNA methylation land-
scapes. Furthermore, our demonstration that the mecha-
nisms underpinning specification of HMRs are mechanis-
tically conserved in zebrafish also suggests this tractable
developmental model system could be exploited through
morpholino or CRISPR based approaches to remove ZF-
CxxC proteins or other contributing mechanisms, individ-
ually or in combination, to further dissect the mechanisms
that shape HMR formation during development.
By examining methylation states across vast expanses of
the same DNA sequence in two completely distinct verte-
brate nuclear environments we provide extensive new evi-
dence that transcription factor binding events are central
determinants in shaping DNA methylation profiles at in-
termediate CpG and GC content regions of the genome.
This parallels observations that dynamic and differential
methylation is often observed at CpG and GC-poor en-
hancer elements across tissues of individual organisms
(8,14–17,54), a feature that in some cases has been at-
tributed to DNA binding transcription factors occupancy
(55,73,74). Importantly, our new trans-species observations
provide chromosome-scale experimental evidence that tran-
scription factor occupancy can help to shape DNA methy-
lation patterns. This is supportive of other single gene
studies that suggested that SP1 transcription factor occu-
pancy could contribute to theDNAmethylation state of the
APRT1 gene (26,27), more limited mutational analysis of
transcription factor binding sites (20,22,23), and the sugges-
tion that single nucleotide variation associated with human
disease affects the capacity of nuclear factors to read the un-
derlying DNA sequence and potentially contributes to al-
terations in the epigenome (75,76). An important step mov-
ing forward will be to determine mechanistically how DNA
binding factors influence DNA methylation. It appears un-
likely that this will simply result from transcription factors
protecting the underlying DNA from the methylation ma-
chinery, as HNF4A lacks CpG dinucleotides in its recogni-
tion sequence yet influences the methylation of surrounding
CpG dinucleotides (73). One interesting possibility is that
transcription factors could exploit active mechanisms, per-
haps through the function of the TET DNA demethylases,
to protect distal gene regulatory sites from the transcrip-
tionally repressive influences of DNA methylation. In sup-
port of this possibility a number of recent studies have pro-
vided preliminary evidence that this may indeed be the case
(55,77).
In summary, through exploiting transchromosomic an-
imal experiments we discover that DNA methylation pat-
terns in vivo are primarily informed and shaped by DNA
sequence. In doing so we demonstrate that classical CGI
like sequences in large genomic regions of DNA can
be interpreted by evolutionarily conserved mechanisms,
even in distantly related vertebrate organisms, to protect
these sequences from DNA methylation and to shape the
epigenome during development.
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